Abstract

This article reviews the current evidence on the cost–effectiveness of psychotherapy for personality disorders (PDs). Although the evidence is still scarce, several well-designed cost–effectiveness studies provide insight into the question – how cost effective is it to reimburse therapies for PDs? This article further argues that the implementation costs and effects should be an integral part of cost–effectiveness analyses to enhance the dissemination of treatment recommendations. Moreover, cost–effectiveness analyses are important in working towards a more patient-centered approach in psychotherapy research that could potentially help accelerate the implementation and adoption of cost-effective care for PDs.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call